ResMed Officer Sandercock Discloses Ongoing Insider Share Sales Under Rule 144

2026-04-06 23:31:09

Abstract generation in progress

ResMed officer Brett Sandercock plans to sell 1,000 shares of vested restricted stock valued at approximately $224,310 under Rule 144. These sales, executed through a Rule 10b5-1 plan adopted in February 2025, are described as routine insider disposals for portfolio diversification rather than an indication of adverse company fundamentals. Sandercock has also sold 3,000 shares in the past three months via pre-arranged transactions.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes